Contact
Please use this form to send email to PR contact of this press release:
PhotoPharmics Completes Pivotal, Phase 3, Light for PD Clinical Trial; to Present Topline Data at World PD Congress
TO:
Spokesperson
PhotoPharmics
+1 801-361-6600